89 results
PRE 14A
ATHA
Athira Pharma Inc
28 Mar 24
Preliminary proxy
8:47am
will be available for examination by any stockholder for any purpose relevant to the annual meeting. If you would like to view the list, please contact … Amendment to the Amended and Restated Certificate of Incorporation
Purpose of the Exculpation Amendment
Effectiveness of the Exculpation Amendment
Vote
S-8
ATHA
Athira Pharma Inc
22 Feb 24
Registration of securities for employees
4:34pm
. (the “Registrant”) for the purpose of registering (a) 1,908,630 additional shares of common stock of the Registrant reserved for issuance under the Athira … Act, including any amendment or report filed for the purpose of updating such description.
All documents filed by the Registrant pursuant
S-8
ATHA
Athira Pharma Inc
22 Feb 24
Registration of securities for employees
4:34pm
of the Registrant’s outstanding shares of Common Stock.
(2)For the sole purpose of calculating the registration fee, the amount to be registered under
8-K
EX-10.1
gbn780gd
22 Feb 24
Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
4:10pm
8-K
EX-10.1
dlpqzi
8 Jan 24
Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update
7:11am
8-K
EX-10.3
r9lemsgr9w 67yh3ye
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
8-K
EX-10.2
td4z4r 85duata20x2
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
8-K
EX-10.1
qps6nqa0ecay3
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
8-K
EX-3.1
fmr1v0m
18 Nov 22
Amendments to Articles of Incorporation or Bylaws
4:05pm
DEFA14A
ky0qqrkwdf
16 May 22
Additional proxy soliciting materials
6:32pm